Navigation Links
Avreo Previews Version 7 RIS/PACS at RSNA
Date:11/27/2011

CHARLESTON, S.C., Nov. 27, 2011 /PRNewswire/ -- As a leader in unified RIS/PACS, Avreo continues to reinvent radiology workflow with its Version 7 release for preview at RSNA.  Version 7 represents an extensive platform change to support key areas of growth including:

  • All new modern design with focus on workflow and usability within radiology and meaningful use.
  • Cross-platform support, including Windows®, Mac OS® X, Apple® iOS, and Android™, to facilitate communication and information exchange, while embracing healthcare professionals' preferred tools. 
  • Advanced business reporting and dashboard visualization to identify trends so your organization can respond with actionable changes.

John Ciccarelli, Avreo Vice President of Sales and Marketing states, "While everyone raced to provide iPad functionality for referring physicians, we took the next step to provide Cross Platform connectivity."  Jonah Still, Avreo Chief Technology Officer continued "These advancements are really important for our customers as they improve usability and direct focus to clinical information while establishing a modern, fresh appearance."

Healthcare organizations can preview these and other Version 7 innovations at RSNA 2011 in Avreo booth 5423, Hall A. 

About Avreo

Avreo, founded in 1997, is a leading provider of Radiology Workflow Solutions for outpatient facilities, multi-specialty organizations, community hospitals, radiology groups, and orthopedic practices.  Our family of innovative solutions combines services from RIS, PACS, Dictation, Transcription, and Automatic Report Distribution within a single application, single database solution to encompass all the features a busy practice or hospital needs to operate efficiently.  Avreo is a privately held company based in Charleston, SC.  Avreo offers solutions on an operational (fee/exam) or capital acquisition payment model.  For more information, visit www.avreo.com or call 1-800-844-9926.


'/>"/>
SOURCE Avreo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
2. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
3. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
8. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
11. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):